| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1091481825 |
| P356 | DOI | 10.1186/S12931-017-0650-6 |
| P932 | PMC publication ID | 5584342 |
| P698 | PubMed publication ID | 28870231 |
| P50 | author | Judit E Pongracz | Q59679839 |
| Krisztián Kvell | Q74598655 | ||
| P2093 | author name string | Luca Jaromi | |
| Gyorgy Miskei | |||
| Judit Rapp | |||
| P2860 | cites work | Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy | Q21245716 |
| Ror2 modulates the canonical Wnt signaling in lung epithelial cells through cooperation with Fzd2 | Q21262984 | ||
| Frizzled-8 as a putative therapeutic target in human lung cancer | Q24298916 | ||
| HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53 | Q24301527 | ||
| Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth | Q24305583 | ||
| Down-regulation of Wnt-4 and up-regulation of Wnt-5a expression by epithelial-mesenchymal transition in human squamous carcinoma cells | Q24306875 | ||
| A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis | Q24307454 | ||
| Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation | Q24319714 | ||
| The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling | Q24540545 | ||
| MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B | Q24564757 | ||
| Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers | Q24595630 | ||
| Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis | Q24608039 | ||
| Why are tumour blood vessels abnormal and why is it important to know? | Q24652018 | ||
| A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma | Q24657797 | ||
| Altered HOX and WNT7A expression in human lung cancer | Q24679566 | ||
| Hyperactive Wnt signaling changes the developmental potential of embryonic lung endoderm | Q24791466 | ||
| Wnt signalling in lung development and diseases | Q25256712 | ||
| Wnt signaling pathway in non-small cell lung cancer | Q26825936 | ||
| Genetic susceptibility to lung cancer--light at the end of the tunnel? | Q26852320 | ||
| Non-canonical WNT signalling in the lung | Q28080483 | ||
| Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling | Q28257009 | ||
| Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer | Q28260824 | ||
| Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma | Q28268844 | ||
| Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship | Q28278682 | ||
| DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway | Q28283034 | ||
| let-7 and miR-17-92: small-sized major players in lung cancer development | Q28291431 | ||
| Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation | Q28306934 | ||
| Genetic variants and risk of lung cancer in never smokers: a genome-wide association study | Q28383607 | ||
| Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer | Q28396304 | ||
| Klotho sensitizes human lung cancer cell line to cisplatin via PI3k/Akt pathway | Q28486480 | ||
| Down-regulation of canonical and up-regulation of non-canonical Wnt signalling in the carcinogenic process of squamous cell lung carcinoma | Q28487775 | ||
| beta-Catenin is required for specification of proximal/distal cell fate during lung morphogenesis | Q28508592 | ||
| Wnt5a regulates Shh and Fgf10 signaling during lung development | Q28509636 | ||
| Expression of Tcf/Lef and sFrp and localization of beta-catenin in the developing mouse lung | Q28587734 | ||
| Wnt5a participates in distal lung morphogenesis | Q28593390 | ||
| Dishevelled-3 C-terminal His single amino acid repeats are obligate for Wnt5a activation of non-canonical signaling | Q28594872 | ||
| Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility | Q28820722 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype | Q29615563 | ||
| Regulation of angiogenesis by hypoxia: role of the HIF system | Q29619187 | ||
| Identification of bronchioalveolar stem cells in normal lung and lung cancer | Q29619267 | ||
| Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma | Q30320422 | ||
| Wnt proteins | Q30420997 | ||
| p53 and microRNA-34 are suppressors of canonical Wnt signaling. | Q30424916 | ||
| Wnt7a stimulates myogenic stem cell motility and engraftment resulting in improved muscle strength. | Q30576111 | ||
| TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program | Q33315569 | ||
| Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches. | Q33392946 | ||
| Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer | Q33720291 | ||
| Cigarette smoke induces C/EBP-β-mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells | Q33737442 | ||
| Overexpression of Wnt5a promotes angiogenesis in NSCLC. | Q33791918 | ||
| The proto-oncogene int-1 encodes a secreted protein associated with the extracellular matrix | Q33919776 | ||
| Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology | Q33949939 | ||
| Fibulin-3 suppresses Wnt/β-catenin signaling and lung cancer invasion. | Q34009946 | ||
| SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity | Q34022836 | ||
| Klotho inhibits growth and promotes apoptosis in human lung cancer cell line A549. | Q34031303 | ||
| Myeloid WNT7b mediates the angiogenic switch and metastasis in breast cancer | Q34063800 | ||
| RORalpha attenuates Wnt/beta-catenin signaling by PKCalpha-dependent phosphorylation in colon cancer | Q34096152 | ||
| Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Q34121219 | ||
| An updated overview on Wnt signaling pathways: a prelude for more | Q34122601 | ||
| Downregulation of GSK3β by miR-544a to maintain self-renewal ability of lung caner stem cells | Q34141601 | ||
| WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer | Q34266112 | ||
| SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells | Q34277248 | ||
| Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin | Q36155017 | ||
| Inhibition of lung cancer cells growth, motility and induction of apoptosis by Klotho, a novel secreted Wnt antagonist, in a dose-dependent manner | Q36312166 | ||
| Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways | Q36313178 | ||
| Functional characterization of pulmonary neuroendocrine cells in lung development, injury, and tumorigenesis | Q36378496 | ||
| Reggie-1/flotillin-2 promotes secretion of the long-range signalling forms of Wingless and Hedgehog in Drosophila | Q36416589 | ||
| DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer | Q36601457 | ||
| Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis | Q36610848 | ||
| Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas | Q36623104 | ||
| Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis | Q36638089 | ||
| Nemo-like kinase regulates the expression of vascular endothelial growth factor (VEGF) in alveolar epithelial cells | Q36755983 | ||
| Matrix metalloproteinase Mmp-1a is dispensable for normal growth and fertility in mice and promotes lung cancer progression by modulating inflammatory responses | Q36850412 | ||
| ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia | Q36893545 | ||
| The role of bevacizumab in the treatment of non-small cell lung cancer: current indications and future developments | Q36982311 | ||
| Nuclear β-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancer. | Q36996781 | ||
| MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway | Q37046669 | ||
| Constitutive expression of human keratin 14 gene in mouse lung induces premalignant lesions and squamous differentiation | Q37090686 | ||
| Insulin-like growth factor-I stimulates differentiation of ATII cells to ATI-like cells through activation of Wnt5a | Q37094220 | ||
| RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. | Q37152947 | ||
| MicroRNA-574-5p promotes metastasis of non-small cell lung cancer by targeting PTPRU. | Q37352550 | ||
| Control of lung epithelial growth by a nicotinic acetylcholine receptor: the other side of the coin. | Q37406151 | ||
| Planar cell polarity signaling: the developing cell's compass. | Q37412656 | ||
| Conditional stabilization of beta-catenin expands the pool of lung stem cells | Q37412788 | ||
| Overexpression of RNF146 in non-small cell lung cancer enhances proliferation and invasion of tumors through the Wnt/β-catenin signaling pathway | Q37479033 | ||
| Sailing with the Wnt: charting the Wnt processing and secretion route | Q37533162 | ||
| Wnt/Planar cell polarity signaling: a new paradigm for cancer therapy | Q37578113 | ||
| Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. | Q37669854 | ||
| Serum level of DKK-1 and its prognostic potential in non-small cell lung cancer | Q37683932 | ||
| Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma. | Q37687546 | ||
| Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling | Q37698281 | ||
| ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling. | Q37719572 | ||
| Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer. | Q37720392 | ||
| Targeting Wnt signaling: can we safely eradicate cancer stem cells? | Q37763415 | ||
| The Role of Wnt Signaling in Physiological and Pathological Angiogenesis | Q37800317 | ||
| Wnt/Ca2+ signaling pathway: a brief overview | Q37929439 | ||
| Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. | Q34293732 | ||
| Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer | Q34323659 | ||
| Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia. | Q34348134 | ||
| β-catenin contributes to lung tumor development induced by EGFR mutations | Q34353437 | ||
| Angiogenesis and lung cancer: prognostic and therapeutic implications | Q34417759 | ||
| Three-dimensional cell culture: the missing link in drug discovery | Q34448808 | ||
| Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis | Q34513567 | ||
| Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer | Q34565071 | ||
| Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma | Q34621127 | ||
| Focus on lung cancer | Q34710709 | ||
| A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer. | Q34768677 | ||
| Activation of the Wnt/planar cell polarity pathway is required for pericyte recruitment during pulmonary angiogenesis. | Q34780828 | ||
| A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells | Q34787867 | ||
| Integrated transcriptomic and epigenomic analysis of primary human lung epithelial cell differentiation. | Q34789360 | ||
| Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium. | Q34876177 | ||
| MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway | Q35025308 | ||
| Simultaneous expression of flotillin-1, flotillin-2, stomatin and caveolin-1 in non-small cell lung cancer and soft tissue sarcomas | Q35095704 | ||
| Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer | Q35101161 | ||
| Expression of flotillin-2 in human non-small cell lung cancer and its correlation with tumor progression and patient survival | Q35145053 | ||
| Klotho is silenced through promoter hypermethylation in gastric cancer. | Q35232389 | ||
| Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer | Q35233122 | ||
| Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures | Q35360217 | ||
| Wnt2 promotes non-small cell lung cancer progression by activating WNT/β-catenin pathway | Q35666419 | ||
| DKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell lines | Q35768464 | ||
| WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis | Q35832964 | ||
| Direct and indirect roles for β-catenin in facultative basal progenitor cell differentiation | Q35850296 | ||
| β-Catenin-SOX2 signaling regulates the fate of developing airway epithelium | Q35851532 | ||
| A pharmacodynamic study of the P-glycoprotein antagonist CBT-1® in combination with paclitaxel in solid tumors. | Q35913254 | ||
| Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis | Q35964137 | ||
| Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer | Q36020906 | ||
| Wnt3a-stimulated LRP6 phosphorylation is dependent upon arginine methylation of G3BP2. | Q36058721 | ||
| Mouse models for human lung cancer | Q36071893 | ||
| Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans | Q36135135 | ||
| Secretion and extracellular space travel of Wnt proteins. | Q38094235 | ||
| Molecular pharmacology of ABCG2 and its role in chemoresistance | Q38135946 | ||
| Strategies for improving outcomes in NSCLC: a look to the future | Q38149345 | ||
| Tankyrases: structure, function and therapeutic implications in cancer | Q38224266 | ||
| Role of MiR-3619-5p in β-Catenin-Mediated Non-Small Cell Lung Cancer Growth and Invasion | Q38295668 | ||
| Germline APC mutation on the beta-catenin binding site is associated with a decreased apoptotic level in colorectal adenomas | Q38358735 | ||
| Targeting the WNT Signaling Pathway in Cancer Therapeutics | Q38573776 | ||
| MicroRNA-376c suppresses non-small-cell lung cancer cell growth and invasion by targeting LRH-1-mediated Wnt signaling pathway | Q38780393 | ||
| Targeting the Wnt-Regulatory Protein CTNNBIP1 by microRNA-214 Enhances the Stemness and Self-Renewal of Cancer Stem-Like Cells in Lung Adenocarcinomas | Q38841574 | ||
| MicroRNA-191, by promoting the EMT and increasing CSC-like properties, is involved in neoplastic and metastatic properties of transformed human bronchial epithelial cells | Q38953681 | ||
| Wnt and Kras signaling-dark siblings in lung cancer | Q39507181 | ||
| Mechanism for nicotine-induced up-regulation of Wnt signaling in human alveolar interstitial fibroblasts | Q39623485 | ||
| Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells | Q39751974 | ||
| Trans-synaptic transmission of vesicular Wnt signals through Evi/Wntless | Q39753324 | ||
| Dishevelled family proteins are expressed in non-small cell lung cancer and function differentially on tumor progression | Q39951928 | ||
| RAGE: developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells. | Q39994864 | ||
| Enhanced Efficacy of Doxorubicin by microRNA-499-Mediated Improvement of Tumor Blood Flow | Q40075702 | ||
| Lung level of HMBG1 is elevated in response to advanced glycation end product-enriched food in vivo. | Q40159504 | ||
| Involvement of Src family kinases in N-cadherin phosphorylation and beta-catenin dissociation during transendothelial migration of melanoma cells. | Q40337286 | ||
| Wnt/β-catenin signaling pathway in lung cancer stem cells is a potential target for the development of novel anticancer drugs. | Q40489852 | ||
| Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. | Q40543122 | ||
| Biological properties and gene expression associated with metastatic potential of human osteosarcoma | Q40608512 | ||
| Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression | Q40625644 | ||
| GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma | Q40764161 | ||
| Constitutive activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mutations in a subset of human lung adenocarcinoma | Q40828450 | ||
| Neovascularization in Glioblastoma: Current Pitfall in Anti-angiogenic therapy | Q41383985 | ||
| Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators | Q41766783 | ||
| Lung cancer in mice induced by the jaagsiekte sheep retrovirus envelope protein is not maintained by rare cancer stem cells, but tumorigenicity does correlate with Wnt pathway activation. | Q42803537 | ||
| The Wnt/calcium pathway activates NF-AT and promotes ventral cell fate in Xenopus embryos | Q43996883 | ||
| Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576. | Q44308417 | ||
| Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival | Q44407580 | ||
| Posttranslational modification of β-catenin is associated with pathogenic fibroblastic changes in bronchopulmonary dysplasia. | Q44804063 | ||
| Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer | Q44980772 | ||
| A protective role for matrix metalloproteinase-3 in squamous cell carcinoma | Q45091349 | ||
| Phosphorylated GSK3beta-ser9 and EGFR are good prognostic factors for lung carcinomas. | Q46922374 | ||
| Altered expression of adhesion molecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesis | Q47349304 | ||
| Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer | Q47794745 | ||
| APC mutations are infrequent but present in human lung cancer | Q47795171 | ||
| Klotho is a novel biomarker for good survival in resected large cell neuroendocrine carcinoma of the lung | Q51743685 | ||
| Frizzled 4 regulates arterial network organization through noncanonical Wnt/planar cell polarity signaling. | Q51847783 | ||
| miR-17-92/p38α Dysregulation Enhances Wnt Signaling and Selects Lgr6+ Cancer Stem-like Cells during Lung Adenocarcinoma Progression. | Q53096425 | ||
| Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs. | Q53179408 | ||
| Mechanism of Wnt/β-catenin signaling pathway in enhanced malignant phenotype of non-small cell lung cancer induced by anti-angiogenesis therapy. | Q53184870 | ||
| Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung. | Q53241385 | ||
| Mechanism of miR-21 via Wnt/β-catenin signaling pathway in human A549 lung cancer cells and Lewis lung carcinoma in mice. | Q53415969 | ||
| Calcitonin driven v-Ha-ras induces multilineage pulmonary epithelial hyperplasias and neoplasms. | Q53420491 | ||
| Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer. | Q53435815 | ||
| Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy. | Q53450807 | ||
| Wnt3 gene expression promotes tumor progression in non-small cell lung cancer. | Q54340040 | ||
| β‐Catenin mutations in pulmonary blastomas: association with morule formation | Q73409912 | ||
| Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer | Q74027845 | ||
| Kinetics of P-glycoprotein-mediated efflux of paclitaxel | Q74372210 | ||
| Disruption of tumor cell adhesion promotes angiogenic switch and progression to micrometastasis in RAF-driven murine lung cancer | Q80783647 | ||
| Synchronous alterations of Wnt and epidermal growth factor receptor signaling pathways through aberrant methylation and mutation in non small cell lung cancer | Q81463886 | ||
| Wnt signaling and stem cell control | Q82703596 | ||
| Abnormal beta-catenin and reduced axin expression are associated with poor differentiation and progression in non-small cell lung cancer | Q83180916 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | lung neoplasm | Q15124212 |
| Wnt proteins | Q77938923 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 167 | |
| P577 | publication date | 2017-09-05 | |
| P1433 | published in | Respiratory Research | Q7315904 |
| P1476 | title | WNT signaling - lung cancer is no exception | |
| P478 | volume | 18 |
Search more.